APP and Alzheimer disease: In the present study of the role of AICD SUMOylation in the context of AD, we found that AICD SUMOylation functions as an endogenous protection mechanism against Aβ toxicity in APP/PS1 mice and mediates the neuroprotective effect of melatonin against AD through enhanced degradation of Aβ.